Announces TripleBlind Exchange: Selfii’s Secure HIPAA-Compliant Health Data Access

Announces TripleBlind Exchange: Selfii’s Secure HIPAA-Compliant Health Data Access Selfii, a leader in privacy-preserving health data solutions for individuals and healthcare organizations, announces the launch of its groundbreaking data marketplace, TripleBlind Exchange. This innovative platform provides secure, HIPAA/GDPR-compliant access to…

Read MoreAnnounces TripleBlind Exchange: Selfii’s Secure HIPAA-Compliant Health Data Access

Healthcare Innovation: WorldQuant Foundry Names Dr. Christopher Mason Senior Advisor

Healthcare Innovation: WorldQuant Foundry Names Dr. Christopher Mason Senior Advisor WorldQuant Foundry, a platform focused on empowering entrepreneurial ventures with data-driven insights and AI-powered solutions, is excited to announce the appointment of Dr. Christopher Mason as Senior Healthcare Advisor. Dr.…

Read MoreHealthcare Innovation: WorldQuant Foundry Names Dr. Christopher Mason Senior Advisor

MedTech Industry Expansion: NAMSA Acquires WuXi AppTec’s U.S. Testing Operations

MedTech Industry Expansion: NAMSA Acquires WuXi AppTec’s U.S. Testing Operations NAMSA, a leading global provider of testing, clinical, and regulatory services for the MedTech industry, has announced an agreement to acquire the medical device testing facilities of WuXi AppTec located…

Read MoreMedTech Industry Expansion: NAMSA Acquires WuXi AppTec’s U.S. Testing Operations

Award Akamai Finalist: Castle’s DecisionDx®-SCC Poster at Maui Derm Hawaii 2025

Award Akamai Finalist: Castle’s DecisionDx®-SCC Poster at Maui Derm Hawaii 2025 Castle Biosciences, Inc. (Nasdaq: CSTL), a company committed to improving patient care through innovative diagnostic tests, will present new data from its dermatologic test portfolio at the Maui Derm…

Read MoreAward Akamai Finalist: Castle’s DecisionDx®-SCC Poster at Maui Derm Hawaii 2025

Atara Biotherapeutics Provides Update on EBVALLO™ (tabelecleucel)

Atara Biotherapeutics Provides Update on EBVALLO™ (tabelecleucel) Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, recently received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for EBVALLO™…

Read MoreAtara Biotherapeutics Provides Update on EBVALLO™ (tabelecleucel)

Healthcare Empowered: Vim Launches Care Insights for Smarter, Data-Driven Decisions

Healthcare Empowered: Vim Launches Care Insights for Smarter, Data-Driven Decisions Vim, a leader in connected healthcare technology and clinical workflow integration, has announced the launch of Care Insights, a revolutionary solution designed to improve healthcare delivery by embedding real-time, patient-specific…

Read MoreHealthcare Empowered: Vim Launches Care Insights for Smarter, Data-Driven Decisions

Cell Therapy Platform Enhanced: Charles River and Akron Bio Integrate CGMP Materials

Cell Therapy Platform Enhanced: Charles River and Akron Bio Integrate CGMP Materials Charles River Laboratories International, Inc. (NYSE: CRL) and Akron Bio, a leading supplier of critical materials and services for advanced therapies, have announced a new collaboration to integrate…

Read MoreCell Therapy Platform Enhanced: Charles River and Akron Bio Integrate CGMP Materials

NextGen Healthcare Launches NextGen® Gastro Suite to Enhance GI Care

NextGen Healthcare Launches NextGen® Gastro Suite to Enhance GI Care NextGen Healthcare, a leader in healthcare technology innovation, has introduced the NextGen® Gastro Suite, a new solution designed to integrate gastroenterology-specific workflows into the NextGen® Enterprise EHR (electronic health record).…

Read MoreNextGen Healthcare Launches NextGen® Gastro Suite to Enhance GI Care